Treasury Chief Rachel Reeves Plans Specific Measures on Living Costs in Forthcoming Budget
Chancellor Reeves has revealed she is planning "targeted measures to deal with household expense issues" in next month's Budget.
During an interview with the BBC, she noted that curbing price rises is a joint task of both the administration and the central bank.
The United Kingdom's price growth is projected to be the most elevated among the Group of Seven developed nations this year and next.
Potential Utility Cost Interventions
Sources suggest the administration could intervene to lower energy bills, for instance by cutting the current 5% rate of value-added tax applied on energy supplies.
An additional approach is to reduce some of the regulatory levies currently included in household expenses.
Fiscal Constraints and Analyst Expectations
The administration will obtain the next draft from the official forecaster, the OBR, on Monday, which will show how much scope there is for such measures.
The expectation from most analysts is that the Chancellor will have to introduce tax rises or budget cuts in order to meet her declared debt limits.
Earlier on the same day, analysis indicated there was a £22bn gap for the Treasury chief to address, which is at the more modest range of projections.
"There's a collective job between the Bank of England and the government to bear down further on some of the drivers of price increases," Reeves informed reporters in Washington, at the annual meetings of the IMF and World Bank.
Tax Commitments and Global Issues
While much of the attention has been on likely tax increases, the Treasury chief said the latest information from the fiscal watchdog had not changed her vow to manifesto promises not to raise tax levels on earnings tax, VAT or National Insurance.
She blamed an "unpredictable world" with growing international and trade issues for the fiscal revenue measures, probably to be targeted on those "wealthiest."
Global Economic Disputes
Referring to apprehensions about the United Kingdom's trade ties with the Asian nation she said: "The UK's national security invariably take priority."
Last week's statement by China to tighten trade restrictions on critical minerals and other materials that are essential for high-technology production led American leader Donald Trump to threaten an further 100% import tax on imports from the Asian country, increasing the possibility of an full-scale trade war between the two largest economies.
The US Treasury Secretary labeled the Chinese action "economic coercion" and "a international production power grab."
Inquired about accepting the US offer to join its battle with the Asian nation, Reeves said she was "extremely troubled" by Chinese actions and urged the Chinese government "not to put up barriers and limit trade."
She said the move was "harmful for the international commerce and creates additional challenges."
"It is my opinion there are sectors where we should address China, but there are also significant chances to export to Chinese markets, including financial services and other sectors of the economic system. We've got to get that balance correct."
The chancellor also stated she was working with international partners "regarding our own essential resources approach, so that we are more independent."
Health Service Medicine Pricing and Funding
The Chancellor also acknowledged that the cost the National Health Service spends on drugs could rise as a result of current discussions with the US government and its drugs companies, in exchange for lower tariffs and funding.
A number of the world's largest pharmaceutical manufacturers have said recently that they are either pausing or abandoning projects in the United Kingdom, with several blaming the modest returns they are obtaining.
Recently, the government science advisor said the price the NHS spends on medicines would have to increase to halt companies and drug research funding leaving the United Kingdom.
Reeves told the BBC: "It has been observed due to the pricing regime, that medical research, recent pharmaceuticals have not been provided in the United Kingdom in the extent that they are in other continental states."
"The objective is to ensure that patients receiving care from the NHS are able to receive the top critical drugs in the globe. And so we are examining this situation, and... aiming to obtain more investment into Britain."